$YTENQ
YIELD10 BIOSCIENCE, INC.

2022 Q4 Form 10-Q Financial Statement

#000112170222000049 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $87.00K $111.0K $92.00K
YoY Change -42.76% 20.65% -54.9%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.403M $1.518M $1.547M
YoY Change -7.82% -1.87% 40.89%
% of Gross Profit
Research & Development $1.888M $2.083M $1.636M
YoY Change 18.15% 27.32% 25.85%
% of Gross Profit
Depreciation & Amortization $66.00K $69.00K $57.00K
YoY Change 20.0% 21.05% 14.0%
% of Gross Profit
Operating Expenses $3.291M $1.518M $1.547M
YoY Change 5.48% -1.87% 40.89%
Operating Profit -$3.490M -$3.091M
YoY Change 12.91% 40.88%
Interest Expense $0.00 $0.00 $700.0K
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $30.00K $10.00K $699.0K
YoY Change -3100.0% -98.57% 1789.19%
Pretax Income -$3.174M -$3.480M -$2.392M
YoY Change 6.9% 45.48% 10.89%
Income Tax $129.0K $9.000K $6.000K
% Of Pretax Income
Net Earnings -$3.303M -$3.489M -$2.398M
YoY Change 10.84% 45.5% 10.61%
Net Earnings / Revenue -3796.55% -3143.24% -2606.52%
Basic Earnings Per Share -$0.71 -$0.49
Diluted Earnings Per Share -$0.67 -$0.71 -$492.1K
COMMON SHARES
Basic Shares Outstanding 4.944M shares 4.914M shares 4.871M shares
Diluted Shares Outstanding 4.925M shares 4.873M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.347M $7.405M $18.52M
YoY Change -72.81% -60.02% 56.97%
Cash & Equivalents $2.356M $3.922M $14.62M
Short-Term Investments $1.991M $3.483M $3.904M
Other Short-Term Assets $641.0K $414.0K $462.0K
YoY Change 47.02% -10.39% 15.5%
Inventory
Prepaid Expenses
Receivables $0.00 $37.00K $24.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.018M $7.895M $19.05M
YoY Change -69.81% -58.57% 54.15%
LONG-TERM ASSETS
Property, Plant & Equipment $775.0K $840.0K $903.0K
YoY Change -12.92% -6.98% -3.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $67.00K $210.0K $278.0K
YoY Change -76.33% -24.46% -7.33%
Total Long-Term Assets $3.067M $3.377M $3.892M
YoY Change -19.1% -13.23% -9.17%
TOTAL ASSETS
Total Short-Term Assets $5.018M $7.895M $19.05M
Total Long-Term Assets $3.067M $3.377M $3.892M
Total Assets $8.085M $11.27M $22.95M
YoY Change -60.4% -50.88% 37.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $109.0K $104.0K $45.00K
YoY Change 31.33% 131.11% -56.31%
Accrued Expenses $926.0K $1.163M $1.122M
YoY Change -18.49% 3.65% 20.65%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.610M $1.826M $1.666M
YoY Change -7.1% 9.6% 12.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.075M $2.226M $9.000K
YoY Change 29542.86% 24633.33% -40.0%
Total Long-Term Liabilities $2.075M $2.226M $9.000K
YoY Change 29542.86% 24633.33% -40.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.610M $1.826M $1.666M
Total Long-Term Liabilities $2.075M $2.226M $9.000K
Total Liabilities $3.685M $4.052M $4.458M
YoY Change -16.04% -9.11% -6.62%
SHAREHOLDERS EQUITY
Retained Earnings -$399.7M -$396.4M -$383.2M
YoY Change 3.51% 3.46% 2.87%
Common Stock $404.3M $403.8M $401.8M
YoY Change 0.5% 0.51% 4.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.400M $7.220M $18.49M
YoY Change
Total Liabilities & Shareholders Equity $8.085M $11.27M $22.95M
YoY Change -60.4% -50.88% 37.85%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$3.303M -$3.489M -$2.398M
YoY Change 10.84% 45.5% 10.61%
Depreciation, Depletion And Amortization $66.00K $69.00K $57.00K
YoY Change 20.0% 21.05% 14.0%
Cash From Operating Activities -$3.062M -$2.702M -$1.992M
YoY Change 23.22% 35.64% -3.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$21.00K -$11.00K
YoY Change -100.0% 90.91%
Acquisitions
YoY Change
Other Investing Activities $1.500M $3.515M $1.017M
YoY Change -122.17% 245.62% -128.33%
Cash From Investing Activities $1.500M $3.494M $1.006M
YoY Change -122.04% 247.32% -128.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -23.00K -20.00K
YoY Change 15.0% -100.37%
NET CHANGE
Cash From Operating Activities -3.062M -2.702M -1.992M
Cash From Investing Activities 1.500M 3.494M 1.006M
Cash From Financing Activities 0.000 -23.00K -20.00K
Net Change In Cash -1.562M 769.0K -1.006M
YoY Change -83.19% -176.44% 235.33%
FREE CASH FLOW
Cash From Operating Activities -$3.062M -$2.702M -$1.992M
Capital Expenditures $0.00 -$21.00K -$11.00K
Free Cash Flow -$3.062M -$2.681M -$1.981M
YoY Change 25.34% 35.34% -3.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33133
dei Entity Registrant Name
EntityRegistrantName
YIELD10 BIOSCIENCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3158289
dei Entity Address Address Line1
EntityAddressAddressLine1
19 Presidential Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Woburn
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01801
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
583-1700
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
YTEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4944202 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3922000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5329000 usd
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
3483000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
10661000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
37000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164000 usd
CY2022Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
39000 usd
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
34000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
414000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
436000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
7895000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
16624000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
840000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
890000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2063000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2354000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
210000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
283000 usd
CY2022Q3 us-gaap Assets
Assets
11272000 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Assets
Assets
20415000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
104000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1163000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1136000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
559000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
514000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1826000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1733000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2226000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2656000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
4052000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4389000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4933288 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4933288 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4881851 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4881851 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
49000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
49000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
403799000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
402283000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-234000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-175000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-396394000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-386131000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7220000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16026000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11272000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20415000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
92000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
363000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
462000 usd
CY2022Q3 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2083000 usd
CY2021Q3 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1636000 usd
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
5862000 usd
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4603000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1518000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1547000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4748000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4583000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
3601000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
3183000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10610000 usd
us-gaap Costs And Expenses
CostsAndExpenses
9186000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3490000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3091000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10247000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8724000 usd
CY2022Q3 yten Gain On Related Party Investment
GainOnRelatedPartyInvestment
0 usd
CY2021Q3 yten Gain On Related Party Investment
GainOnRelatedPartyInvestment
700000 usd
yten Gain On Related Party Investment
GainOnRelatedPartyInvestment
0 usd
yten Gain On Related Party Investment
GainOnRelatedPartyInvestment
700000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
699000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
698000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3480000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2392000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10236000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8026000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3489000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2398000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10263000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.71
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.71
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4924606 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4924606 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4873248 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4873248 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4904737 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4904737 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4681292 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4681292 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3489000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2398000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10263000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
20000 usd
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-34000 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-17000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-57000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-17000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-59000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3503000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2415000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10322000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8062000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10263000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
197000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165000 usd
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
111000 usd
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1458000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1175000 usd
yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
291000 usd
yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
265000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
37000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
24000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-127000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-62000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
5000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
19000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-52000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-60000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-192000 usd
yten Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-385000 usd
yten Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-342000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8342000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8342000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6768000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6768000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
154000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1195000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3874000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
8371000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
6250000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7022000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7022000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2229000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2229000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4186000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14882000 usd
yten Proceeds From Warrant Exercises Net
ProceedsFromWarrantExercisesNet
0 usd
yten Proceeds From Warrant Exercises Net
ProceedsFromWarrantExercisesNet
3856000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
11993000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
103000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15746000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15746000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-50000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1407000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11195000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5593000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3687000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10271000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
446000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
29000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
23000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-3489000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7220000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
20462000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
436000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
24000 usd
CY2021Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
19000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-17000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2398000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
18488000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16026000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1458000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
95000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
37000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-59000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10263000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
7220000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9532000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1185000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
86000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3856000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
102000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11993000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-11000 usd
us-gaap Net Income Loss
NetIncomeLoss
-8051000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
18488000 usd
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
7405000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3922000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5329000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4186000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5593000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;padding-right:4.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of grant revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, short-term investments and accounts receivable. The Company has historically invested its cash in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company’s investment policy which establishes a concentration limit per issuer.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2271183 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3087775 shares
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10669000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10661000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
386000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
452000 usd
CY2022Q3 yten Accrued Lease Cost
AccruedLeaseCost
61000 usd
CY2021Q4 yten Accrued Lease Cost
AccruedLeaseCost
71000 usd
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
237000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
264000 usd
CY2022Q3 yten Accrued Field Trials And Related Expenses Current
AccruedFieldTrialsAndRelatedExpensesCurrent
342000 usd
CY2021Q4 yten Accrued Field Trials And Related Expenses Current
AccruedFieldTrialsAndRelatedExpensesCurrent
97000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
137000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
252000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1163000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1136000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
447000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1458000 usd
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
436000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1175000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
244092 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
166702 shares
CY2022Q1 yten Share Based Compensation Arrangement By Share Based Payment Award Additional Shares Authorized Percent
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent
0.05
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
300000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
25961 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
10912 shares
yten Payment Tax Withholding Share Based Payment Arrangement Excluding Employer Amount
PaymentTaxWithholdingShareBasedPaymentArrangementExcludingEmployerAmount
34000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
183000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
749000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
771000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
793000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
747000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3243000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
460000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2783000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
559000 usd
CY2022Q3 yten Operating Lease Liability Noncurrent Excluding Lease Included On Balance Sheet
OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet
2224000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
151000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
151000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
454000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
454000 usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
177000 usd
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
171000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
509000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
497000 usd
CY2022Q3 us-gaap Sublease Income
SubleaseIncome
155000 usd
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
148000 usd
us-gaap Sublease Income
SubleaseIncome
450000 usd
us-gaap Sublease Income
SubleaseIncome
468000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
173000 usd
CY2021Q3 us-gaap Lease Cost
LeaseCost
174000 usd
us-gaap Lease Cost
LeaseCost
513000 usd
us-gaap Lease Cost
LeaseCost
483000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0725
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0725
CY2022Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
22213 sqft
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3243000 usd
CY2020Q4 yten Collaborative Arrangement Term
CollaborativeArrangementTerm
P2Y
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
92000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
363000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
462000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
840000 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
903000 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1290273 shares
CY2022Q2 yten Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
1071453 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3856000 usd
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2271183 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3093921 shares

Files In Submission

Name View Source Status
yten-20220930_cal.xml Edgar Link unprocessable
yten-20220930_pre.xml Edgar Link unprocessable
yten-20220930_htm.xml Edgar Link completed
yten-20220930_def.xml Edgar Link unprocessable
yten-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001121702-22-000049-index-headers.html Edgar Link pending
0001121702-22-000049-index.html Edgar Link pending
0001121702-22-000049.txt Edgar Link pending
0001121702-22-000049-xbrl.zip Edgar Link pending
ex-311x20220930.htm Edgar Link pending
ex-312x20220930.htm Edgar Link pending
ex-321x20220930.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yten-20220930.htm Edgar Link pending
yten-20220930.xsd Edgar Link pending